ImmuCell Corp. (ICCC)
9.75
+0.15
(+1.56%)
USD |
NASDAQ |
Oct 02, 16:00
ImmuCell Market Cap : 88.55M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 88.55M |
| October 01, 2026 | 87.19M |
| September 30, 2026 | 89.01M |
| September 29, 2026 | 90.28M |
| September 28, 2026 | 89.73M |
| September 25, 2026 | 90.14M |
| September 24, 2026 | 90.55M |
| September 23, 2026 | 90.73M |
| September 22, 2026 | 90.73M |
| September 21, 2026 | 92.00M |
| September 18, 2026 | 90.37M |
| September 17, 2026 | 90.64M |
| September 16, 2026 | 87.28M |
| September 15, 2026 | 87.01M |
| September 14, 2026 | 88.19M |
| September 11, 2026 | 89.46M |
| September 10, 2026 | 90.05M |
| September 09, 2026 | 90.00M |
| September 08, 2026 | 89.37M |
| September 04, 2026 | 89.91M |
| September 03, 2026 | 90.82M |
| September 02, 2026 | 90.82M |
| September 01, 2026 | 90.10M |
| August 31, 2026 | 88.91M |
| August 28, 2026 | 90.28M |
| Date | Value |
|---|---|
| August 27, 2026 | 91.00M |
| August 26, 2026 | 91.00M |
| August 25, 2026 | 89.37M |
| August 24, 2026 | 89.37M |
| August 21, 2026 | 91.37M |
| August 20, 2026 | 91.64M |
| August 19, 2026 | 92.00M |
| August 18, 2026 | 88.64M |
| August 17, 2026 | 88.10M |
| August 14, 2026 | 91.28M |
| August 13, 2026 | 99.00M |
| August 12, 2026 | 99.72M |
| August 11, 2026 | 99.45M |
| August 10, 2026 | 99.24M |
| August 07, 2026 | 99.51M |
| August 06, 2026 | 99.70M |
| August 05, 2026 | 97.25M |
| August 04, 2026 | 100.15M |
| August 03, 2026 | 99.88M |
| July 31, 2026 | 101.41M |
| July 30, 2026 | 100.06M |
| July 29, 2026 | 99.61M |
| July 28, 2026 | 101.69M |
| July 27, 2026 | 100.69M |
| July 24, 2026 | 99.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| PE Ratio | 116.35 |
| PS Ratio | 2.887 |
| Price to Book Value | 2.822 |
| Price to Free Cash Flow | 21.01 |
| Price | 9.75 |
| Earnings Yield | 0.86% |
| Operating PE Ratio | 47.45 |
| Normalized PE Ratio | 70.70 |